BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu H, Zhong Z, Wang A, Yuan C, Ning K, Hu H, Wang C, Yin X. LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1/M2 polarization of Kupffer cells. Cancer Cell Int 2020;20:266. [PMID: 32595415 DOI: 10.1186/s12935-020-01354-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang H, Mi S, Brito LF, Hu L, Wang L, Ma L, Xu Q, Guo G, Yu Y, Wang Y. Genomic and transcriptomic analyses enable the identification of important genes associated with subcutaneous fat deposition in Holstein cows. J Genet Genomics 2023:S1673-8527(23)00026-7. [PMID: 36738887 DOI: 10.1016/j.jgg.2023.01.011] [Reference Citation Analysis]
2 Tang B, wang H, Wang Y, Lai S, Zhao L, Liu W, Liu S, Chen H, Wang J, Du G. LINC01468 drives NAFLD-HCC progression through CUL4A-linked degradation of SHIP2.. [DOI: 10.21203/rs.3.rs-2051343/v1] [Reference Citation Analysis]
3 Rusu I, Pirlog R, Chiroi P, Nutu A, Puia VR, Fetti AC, Rusu DR, Berindan-Neagoe I, Al Hajjar N. The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC. Int J Mol Sci 2022;23:12370. [PMID: 36293225 DOI: 10.3390/ijms232012370] [Reference Citation Analysis]
4 Kazeminasab F, Baharlooie M, Ghaedi K, Mandard S. Noncoding RNAs Associated with PPARs in Etiology of MAFLD as a Novel Approach for Therapeutics Targets. PPAR Research 2022;2022:1-13. [DOI: 10.1155/2022/6161694] [Reference Citation Analysis]
5 Yang J, Qu T, Li Y, Ma J, Yu H. Biological role of long non-coding RNA FTX in cancer progression. Biomedicine & Pharmacotherapy 2022;153:113446. [DOI: 10.1016/j.biopha.2022.113446] [Reference Citation Analysis]
6 He Q, Guo P, Bo Z, Yu H, Yang J, Wang Y, Chen G. Noncoding RNA-mediated molecular bases of chemotherapy resistance in hepatocellular carcinoma. Cancer Cell Int 2022;22:249. [PMID: 35945536 DOI: 10.1186/s12935-022-02643-6] [Reference Citation Analysis]
7 Lu Y, Ma S, Ding W, Sun P, Zhou Q, Duan Y, Sartorius K. Resident Immune Cells of the Liver in the Tumor Microenvironment. Front Oncol 2022;12:931995. [DOI: 10.3389/fonc.2022.931995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Liu H, Niu Q, Wang T, Dong H, Bian C. Lipotoxic hepatocytes promote nonalcoholic fatty liver disease progression by delivering microRNA-9-5p and activating macrophages. Int J Biol Sci 2021;17:3745-59. [PMID: 35261562 DOI: 10.7150/ijbs.57610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Jin SS, Lin CJ, Lin XF, Zheng JZ, Guan HQ. Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathway. Ann Hepatol 2022;27:100584. [PMID: 34808393 DOI: 10.1016/j.aohep.2021.100584] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
10 Cui J, Wang Y, Xue H. Long non-coding RNA GAS5 contributes to the progression of nonalcoholic fatty liver disease by targeting the microRNA-29a-3p/NOTCH2 axis. Bioengineered 2022;13:8370-81. [PMID: 35322757 DOI: 10.1080/21655979.2022.2026858] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Mirshahi F, Aqbi HF, Isbell M, Manjili SH, Guo C, Saneshaw M, Dozmorov M, Khosla A, Wack K, Carrasco-Zevallos OM, Idowu MO, Wang XY, Sanyal AJ, Manjili MH, Bandyopadhyay D. Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma. Cell Rep 2022;38:110454. [PMID: 35235789 DOI: 10.1016/j.celrep.2022.110454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhang C, Liu S, Yang M. Functions of two distinct Kupffer cells in the liver. Exploration of Medicine. [DOI: 10.37349/emed.2021.00067] [Reference Citation Analysis]
13 Guo B, Cheng Y, Yan L, Zhang J, Lu J, Qi H, Chen H. LncRNA HOTAIR regulates the lipid accumulation in non-alcoholic fatty liver disease via miR-130b-3p/ROCK1 axis. Cell Signal 2021;:110190. [PMID: 34774989 DOI: 10.1016/j.cellsig.2021.110190] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Chen X, Ma H, Gao Y, Jin Y, Ning W, Hou Y, Su J. Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2. Bioengineered 2021;12:6738-47. [PMID: 34511037 DOI: 10.1080/21655979.2021.1960463] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Ghafouri-Fard S, Abak A, Tavakkoli Avval S, Shoorei H, Taheri M, Samadian M. The impact of non-coding RNAs on macrophage polarization. Biomed Pharmacother 2021;142:112112. [PMID: 34449319 DOI: 10.1016/j.biopha.2021.112112] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
16 Liu Y, Wu Y, Liu S, Dai Y. Long Non-Coding RNA TRIM52-AS1 Promotes Growth and Metastasis via miR-218-5p/ROBO1 in Hepatocellular Carcinoma. Cancer Manag Res 2021;13:547-58. [PMID: 33519234 DOI: 10.2147/CMAR.S286205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
17 张 剑. Effect of Kupffer Cells in the Pathogenesis of Primary Liver Cancer. ACM 2021;11:1726-1732. [DOI: 10.12677/acm.2021.114248] [Reference Citation Analysis]
18 Hong GQ, Cai D, Gong JP, Lai X. Innate immune cells and their interaction with T cells in hepatocellular carcinoma. Oncol Lett 2021;21:57. [PMID: 33281968 DOI: 10.3892/ol.2020.12319] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]